Brand check
Is Eno banned in India?
Last checked 19 September 2026
Eno is not banned in India as of 19 Sep 2026; it is an over-the-counter antacid of sodium bicarbonate and citric acid that has never been named in any notification.
- Classification
- No ban or recall found in official records
- Decided by
- CDSCO / Ministry of Health and Family Welfare
- Reference
- No Section 26A notification for Eno or its ingredients
- Latest action
- 19 September 2026
- Last checked
- 19 September 2026
Historic Eno's Fruit Salt advertisement (1911, public domain). Photo: Eno's 'Fruit Salt' advertisement 001.jpg by The Graphic (Public domain). Brand names and logos belong to their owners and are used here to identify the product this entry is about. All photo credits.
CDSCO: Drugs banned in India (consumer section)
Scope. A record here does not by itself mean a product or company is unsafe or banned today. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Below: Blacklisted's explanationWe organise and explain what the document says. The document above is the authority.
Key facts
- Governing authority
- CDSCO, Ministry of Health and Family Welfare
- Ban notification
- None
- Marketer
- Haleon (formerly GSK Consumer Healthcare)
- Composition
- Sodium bicarbonate, citric acid, sodium carbonate
- Label caution
- High sodium; people on salt-restricted diets or with kidney or heart disease should ask a doctor
Where the claim comes from
Eno has never been in regulatory news. 'Is Eno banned in India' appears alongside searches about Pan-D counterfeits, the ranitidine review and the 2023 Digene recall, as consumers check the acidity brand they use most. There is no event behind it.
Eno is a fruit-salt antacid, sodium bicarbonate, citric acid and sodium carbonate, that fizzes in water and neutralises stomach acid within minutes. It is one of the oldest over-the-counter brands in India, marketed by Haleon, and it is not banned.
We can find no regulatory action of any kind involving Eno. Its ingredients are simple salts, it is not a fixed-dose combination of the type the Health Ministry has been prohibiting, and it has not appeared in the CDSCO's monthly quality alerts in the period we have reviewed. The question appears to be a by-product of other acidity news: the counterfeit Pan-D batches flagged in 2024 and 2025, the long-running review of ranitidine over NDMA, and the September 2023 recall of Digene gel batches by Abbott. Each of those stories sends consumers to check the brand in their own kitchen cupboard.
The only caution worth stating is on the label. A sachet of Eno contains a large amount of sodium, and people on salt-restricted diets, with high blood pressure, heart failure or kidney disease should ask a doctor before regular use. Frequent heartburn that needs Eno most days is also a reason to see a doctor rather than a reason to worry about a ban.
If a CDSCO alert ever names an Eno batch, that finding would apply to the batch listed; compare the number on the sachet.
What this means for you
Use as before
Eno is sold over the counter and is not the subject of any regulatory action.
Mind the salt
Each sachet carries a substantial sodium load; that is a label matter for people with blood-pressure or kidney problems.
This is a record of official orders, not medical advice. Do not stop a prescribed medicine without asking your doctor or pharmacist.
Batches flagged in CDSCO alerts
No NSQ batch on record. No product matching this name appears in CDSCO or state-lab NSQ alerts from Jan 2019 to July 2026. Absence from the alerts is not proof of quality, check your batch number.
Official sources and primary records
- Regulator
- Regulator